Case report: Primary hepatocellular carcinoma with portal vein tumor thrombus characterized by active tumor immune microenvironment achieving a complete response following treatment of combined immunotherapy

被引:3
|
作者
Zhong, Kaihang [1 ]
Xu, Yuyan [1 ]
Cheng, Yuan [1 ]
Wen, Yaohong [1 ]
Cai, Lei [1 ]
He, Guolin [1 ]
Huang, Huakun [1 ]
Fu, Shunjun [1 ]
Zhong, Xuefeng [2 ]
Zheng, Yating [2 ]
Chen, Tingting [2 ]
Huang, Mengli [2 ]
Pan, Mingxin [1 ]
机构
[1] Southern Med Univ, Zhujiang Hosp, Gen Surg Ctr, Dept Hepatobiliary Surg 2, Guangzhou, Peoples R China
[2] 3D Med Inc, Med Dept, Shanghai, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2022年 / 13卷
基金
中国国家自然科学基金;
关键词
hepatocellular carcinoma (HCC); portal vein tumor thrombus (PVTT); tumor immune microenvironment (TIME); tertiary lymphoid structure (TLS); combined immunotherapy; B-CELLS; SURVIVAL; SORAFENIB; RESECTION;
D O I
10.3389/fimmu.2022.999763
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Portal vein tumor thrombus (PVTT) is a frequent complication in hepatocellular carcinoma (HCC). HCC patients with PVTT have the characteristics of less treatment tolerance and poor prognosis. Immunotherapy, especially combined immunotherapy, has been successfully used in advanced HCC. However, there are no recognized universally indicators that can predict response or resistance to immunotherapy for HCC. Herein, we reported a 58-year-old HCC patient with PVTT, cirrhosis and chronic viral hepatitis, who achieved complete response (CR) after combined immunotherapy (camrelizumab combined with sorafenib or regorafenib), according to his high enrichment of tumor-infiltrating immune cells and tertiary lymphoid structure (TLS). In this case, we revealed the characteristics of the baseline tumor immune microenvironment (TIME) in a HCC patient who responded well to combined immunotherapy, suggesting that TIME can be used to assist in clinical decision making of immunotherapy for HCC.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] The safety and efficacy of percutaneous ethanol injection in the treatment of tumor thrombus in advanced hepatocellular carcinoma with portal vein tumor thrombus
    Sun, Bo
    Zhang, Weihua
    Chen, Lei
    Sun, Tao
    Ren, Yanqiao
    Zhu, Licheng
    Qian, Kun
    Zheng, Chuansheng
    ABDOMINAL RADIOLOGY, 2022, 47 (02) : 858 - 868
  • [42] The safety and efficacy of percutaneous ethanol injection in the treatment of tumor thrombus in advanced hepatocellular carcinoma with portal vein tumor thrombus
    Bo Sun
    Weihua Zhang
    Lei Chen
    Tao Sun
    Yanqiao Ren
    Licheng Zhu
    Kun Qian
    Chuansheng Zheng
    Abdominal Radiology, 2022, 47 : 858 - 868
  • [43] Therapeutic value of transcatheter arterial chemoembolization combined with portal vein embolization for primary hepatocellular carcinoma with portal vein tumor thrombus: A pilot study
    Tan, Xuefen
    Xie, Peng
    Liu, Jibing
    Wu, Huiyong
    Xie, Yinfa
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2015, 11 (03) : E6 - E12
  • [44] INTRABEAM intraoperative radiotherapy combined with portal vein infusion chemotherapy for treating hepatocellular carcinoma with portal vein tumor thrombus
    Song, Xiaodong
    He, Yong
    Liang, Huihong
    Han, Menling
    Shao, Zili
    BMC SURGERY, 2020, 20 (01)
  • [45] INTRABEAM intraoperative radiotherapy combined with portal vein infusion chemotherapy for treating hepatocellular carcinoma with portal vein tumor thrombus
    Xiaodong Song
    Yong He
    Huihong Liang
    Menling Han
    Zili Shao
    BMC Surgery, 20
  • [46] Surgery for colloid carcinoma of the pancreas with portal vein tumor thrombus: a case report
    Udagawa, Daisuke
    Shimazu, Motohide
    Sakuragawa, Tadayuki
    Maruyama, Shotaro
    Uchi, Yusuke
    Miura, Eisuke
    Masugi, Yohei
    Sakamoto, Michiie
    SURGICAL CASE REPORTS, 2020, 6 (01)
  • [47] Surgery for colloid carcinoma of the pancreas with portal vein tumor thrombus: a case report
    Daisuke Udagawa
    Motohide Shimazu
    Tadayuki Sakuragawa
    Shotaro Maruyama
    Yusuke Uchi
    Eisuke Miura
    Yohei Masugi
    Michiie Sakamoto
    Surgical Case Reports, 6
  • [48] Complete response to tremelimumab plus durvalumab treatment in hepatocellular carcinoma with a bile duct tumor thrombus: A case report
    Ishihara, Nobuaki
    Komatsu, Shohei
    Kido, Masahiro
    Gon, Hidetoshi
    Fukushima, Kenji
    Urade, Takeshi
    Yoshida, Toshihiko
    Arai, Keisuke
    Yanagimoto, Hiroaki
    Toyama, Hirochika
    Fukumoto, Takumi
    ONCOLOGY LETTERS, 2024, 28 (01)
  • [49] Indications and treatment of hepatocellular carcinoma with portal vein tumor thrombus based on two classifications
    Ye, Jiazhou
    Ye, Haihong
    Xie, Si
    Duan, Wenlong
    Bai, Tao
    Chen, Jie
    Ma, Liang
    Xiang, Bangde
    Li, Lequn
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (06): : 9021 - 9032
  • [50] Efficacy of transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma with tumor thrombus in the portal vein
    Liao, W
    Guo, Q
    Liu, Z
    RADIOLOGY, 2000, 217 : 503 - 503